---
title: "Lycia Therapeutics surges 8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303612779.md"
description: "Lycia Therapeutics rose 8.10% to US$27.08."
datetime: "2026-10-29T18:19:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303612779.md)
  - [en](https://longbridge.com/en/news/303612779.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303612779.md)
generator: "portal-rs"
---

# Lycia Therapeutics surges 8%

Lycia Therapeutics (LYCA.US) surged more than **8%** during regular trading to **$27.08**.

The Nasdaq Composite is up 0.47% over the past five sessions.

Lycia Therapeutics listed on the Nasdaq on Oct. 23, 2026, at an IPO price of $18, raising $317.5 million. Shares closed at $30 on the first day of trading, valuing the company at approximately $1.563 billion.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [LYCA.US](https://longbridge.com/en/quote/LYCA.US.md)

## Related News & Research

- [Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference | LYCA Stock News](https://longbridge.com/en/news/305169503.md)
- [Venrock Healthcare Capital Partners III, Affiliates Report Acquisition of $223,819.75 in Lycia Therapeutics Common Shares](https://longbridge.com/en/news/304347845.md)
- [Is the Stock Market Going to Crash? Warren Buffett's Warning Is Hard to Ignore.](https://longbridge.com/en/news/305154637.md)
- [CoreWeave CEO Says He Has Buyers for All Its Future AI Capacity but Won’t Sell Yet](https://longbridge.com/en/news/305196611.md)
- [INSTANT VIEW-Nvidia board meets to decide CEO Huang's future, source says](https://longbridge.com/en/news/305229382.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**